Explore barriers to biosimilar adoption, such as PBM practices, regulatory limitations, and provider and patient level friction and learn what employers can do to promote uptake.

Discover how vertical integration and pricing manipulation by PBMs are limiting biosimilar access—and what employers can do to ensure savings and transparency.

Same drug, same pharmacy—very different outcomes. See how legacy PBMs inflate costs through spread and rebate retention, and how SmithRx lowers them through transparency and true alignment.